Habib J. Dable - 16 Apr 2026 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Reporting relationship: Director
Issuer ticker: TYRA
Reported as of: 16 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 20 Apr 2026, 16:31:02 UTC
Prior SEC filing: 05 Feb 2026
Next SEC filing: 23 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Ali D. Fawaz, Attorney-in-Fact

Key filing fact

Habib J. Dable filed Form 4 for Tyra Biosciences, Inc. (TYRA) on 20 Apr 2026.

Key facts

This page summarizes Habib J. Dable's Form 4 filing for Tyra Biosciences, Inc. (TYRA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 20 Apr 2026, 16:31.

Change

Previous filing in this sequence was filed on 05 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001690773 Primary reporting owner

Dable Habib J

Relationship: Director
Address: C/O TYRA BIOSCIENCES, INC., 2656 STATE STREET, CARLSBAD
Signature: /s/ Ali D. Fawaz, Attorney-in-Fact
Signature date: 20 Apr 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TYRA transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +44,400
Change %
Price: $0.000000^*
Shares after: 44,400
Date: 16 Apr 2026
Ownership: Direct
Underlying class: Common
Underlying amount: 44,400
Exercise price: $35.12
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

1/36th of the total number of shares of common stock subject to the option vest monthly following April 16, 2026, the date of grant, subject to the Reporting Person's continuous service to the Issuer through each vesting date.